948
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway

ORCID Icon, , , , , & show all
Pages 2790-2801 | Received 07 Aug 2018, Accepted 02 Nov 2018, Published online: 18 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Weiyu Wang, Yufan Ying, Haiyun Xie, Jiangfeng Li, Xueyou Ma, Liujia He, Mingjie Xu, Shiming Chen, Haixiang Shen, Xiangyi Zheng, Ben Liu, Xiao Wang & Liping Xie. (2021) miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis. Cell Cycle 20:13, pages 1242-1252.
Read now

Articles from other publishers (20)

Xin Lin, Yang Yang, Ye Ji, Guangxi Wang, Wenbo Xu, Bo Wang, Hangyu Guo, Jiyu Ren, Jinglong Yan & Nanxiang Wang. (2023) MiR-135a-5p/SP1 Axis Regulates Spinal Astrocyte Proliferation and Migration. Neuroscience 515, pages 12-24.
Crossref
Yuhang Zhang, Wenyu Wang, Hang Zhou & Yimin Cui. (2023) Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway. Cancers 15:3, pages 809.
Crossref
荣 刘. (2023) Research Progress on the Relationship between miR-125a-5p and Pulmonary Tuberculosis. Advances in Clinical Medicine 13:05, pages 7410-7416.
Crossref
Zhiqiang Chen. (2023) The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway. Urologia Internationalis 107:9, pages 848-856.
Crossref
Aaron Perecman, Adam Wiggins, Jonathan Xu, Sanjna Das, Thomas Kalantzakos, Travis Sullivan & Kimberly Rieger-Christ. 2022. Urologic Cancers. Urologic Cancers 29 43 .
Jiazhu Sun, Xueyou Ma, Yufan Ying, Weiyu Wang, Haixiang Shen, Song Wang, Haiyun Xie, Jiahe Yi, Weitao Zhan, Jiangfeng Li & Ben Liu. (2022) SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer. Cell Death Discovery 8:1.
Crossref
Xiaoyan Wang, Lian He, Yan Wang, Yunyun Liu, Yuxin Wang, Dandan Chen, Dandan Gong & Yu Fan. (2022) MiR-300 Alleviates Cell Proliferation and Migration and Facilitates Cell Apoptosis by Targeting c-Met in Gastric Cancer. Journal of Oncology 2022, pages 1-10.
Crossref
Li-Hui ZHANG, Wan-Ying ZHANG, Jia-Ming XIONG, Xiu-Mei DUAN, Li-Na HAI, Yu-Liang ZHANG, Miao-Miao ZHANG, Gui-Fang QIN & Guo-Wei ZHANG. (2022) Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation. Chinese Journal of Natural Medicines 20:1, pages 43-53.
Crossref
Mei Wang, Ying Tian, Lin Miao & Wenxia Zhao. (2021) MicroRNA-300 Inhibits the Proliferation and Metastasis of Cervical Cancer Cells via Posttranscriptional Suppression of G Protein-Coupled Receptor 34 (GPR34). Journal of Oncology 2021, pages 1-10.
Crossref
Amro M. Soliman, Mohamed Soliman, Srijit Das & Seong Lin Teoh. (2021) MicroRNA as a Biomarker for Diagnostic, Prognostic, and Therapeutic Purpose in Urinary Tract Cancer. Processes 9:12, pages 2136.
Crossref
Muskan Bhatia, Mihir Bhalerao, Natália Cruz‐Martins & Dileep Kumar. (2021) Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways. Phytotherapy Research 35:9, pages 4913-4929.
Crossref
Chaoyuan Huang, Xiaotao Jiang, Yuancheng Huang, Lina Zhao, Peiwu Li & Fengbin Liu. (2021) Identifying Dendritic Cell–Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis. Frontiers in Molecular Biosciences 8.
Crossref
Lei Zhang, Yashi Ruan, Zhiqiang Qin, Xian Gao, Kai Xu, Xiaokai Shi, Shenglin Gao, Shouyong Liu, Kai Zhu, Wei Wang, Li Zuo, Lifeng Zhang & Wei Zhang. (2021) miR-483-3p, Mediated by KLF9, Functions as Tumor Suppressor in Testicular Seminoma via Targeting MMP9. Frontiers in Oncology 10.
Crossref
Ying Wang, Feifei Huang, Ming Liu & Quan Zhao. (2021) UBE2C mRNA expression controlled by miR-300 and HuR determines its oncogenic role in gastric cancer. Biochemical and Biophysical Research Communications 534, pages 597-603.
Crossref
Yu Wang, Lei Dou, Yun Qin, Huiyuan Yang & Peng Yan. (2020) OIP5-AS1 contributes to tumorigenesis in hepatocellular carcinoma by miR-300/YY1-activated WNT pathway. Cancer Cell International 20:1.
Crossref
Sophie E. Ruff, Susan K. Logan, Michael J. Garabedian & Tony T. Huang. (2020) Roles for MDC1 in cancer development and treatment. DNA Repair 95, pages 102948.
Crossref
Erna Marija Meškytė, Sabiha Keskas & Yari Ciribilli. (2020) MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis. International Journal of Molecular Sciences 21:20, pages 7710.
Crossref
Bo Hong, Jie Li, Chunxiao Huang, Tao Huang, Mengpei Zhang & Lijiang Huang. (2020) miR-300/FA2H affects gastric cancer cell proliferation and apoptosis. Open Medicine 15:1, pages 882-889.
Crossref
Hejia Zhu, Song Wang, Haixiang Shen, Xiangyi Zheng & Xin Xu. (2020) SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma. Frontiers in Cell and Developmental Biology 8.
Crossref
Xian-bin Liu, Jing Wang, Ke Li & Xian-nan Fan. (2019) Sp1 promotes cell migration and invasion in oral squamous cell carcinoma by upregulating Annexin A2 transcription. Molecular and Cellular Probes 46, pages 101417.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.